{"Data":[{"Comment":">= 40 - < 50 %","GroupName":"Carcinogenic, mutagenic, reprotoxic (CMR) substances, Category 1A, 1B and 2 under Part 3 Annex VI to EC regulation 1272/2008","GroupNameDisplay":"CMR Substances Europe","SubstanceName":"CYCLOHEXYLAMINE","CasNumber":"108-91-8","Concentration":50.0,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"18841e18-2928-4f37-9517-0cb5fcaa2af5","GroupQuestionIdentifier":"Q3001Carcinogenic","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "},{"Comment":">= 20 - < 30 %","GroupName":"Corrosive/Irritating substances as listed in Cat 1&2 Reg 1272/2008","GroupNameDisplay":"Corrosive/Irritating Substances","SubstanceName":"2-diethylaminoethanol","CasNumber":"100-37-8","Concentration":30.0,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"c9d66026-9dcf-498e-b6a3-46678f197362","GroupQuestionIdentifier":"Q3001CorrosiveSubstances","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "},{"Comment":">= 15 - < 20 %","GroupName":"Corrosive/Irritating substances as listed in Cat 1&2 Reg 1272/2008","GroupNameDisplay":"Corrosive/Irritating Substances","SubstanceName":"Morpholine","CasNumber":"110-91-8","Concentration":20.0,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"1ad0a547-2f2a-49b0-aefa-8996a9f8f75f","GroupQuestionIdentifier":"Q3001CorrosiveSubstances","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "},{"Comment":"< 0.1","GroupName":"Endocrine disruptors as listed in Reg 2017/745 Annex I, 10.4.1 (b)","GroupNameDisplay":"Endocrine Disruptors","SubstanceName":"ETHYLENE GLYCOL MONOMETHYL ETHER","CasNumber":"109-86-4","Concentration":0.1,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"3c0835c5-a700-4758-81ec-603aa58db61e","GroupQuestionIdentifier":"Q3001SubGrp19","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "},{"Comment":"< 0.005 % as impurity","GroupName":"Endocrine disruptors as listed in Reg 2017/745 Annex I, 10.4.1 (b)","GroupNameDisplay":"Endocrine Disruptors","SubstanceName":"BENZENE","CasNumber":"71-43-2","Concentration":0.005,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"03e17b1c-ef6a-44a6-8a53-5ff78405d025","GroupQuestionIdentifier":"Q3001SubGrp19","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "},{"Comment":"< 0.005 % as impurity","GroupName":"Endocrine disruptors as listed in Reg 2017/745 Annex I, 10.4.1 (b)","GroupNameDisplay":"Endocrine Disruptors","SubstanceName":"ANILINE","CasNumber":"62-53-3","Concentration":0.005,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"f7404ac8-a775-43c5-9bc5-968f9a17d4eb","GroupQuestionIdentifier":"Q3001SubGrp19","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "},{"Comment":"< 0.1 % as impurity","GroupName":"Endocrine disruptors as listed in Reg 2017/745 Annex I, 10.4.1 (b)","GroupNameDisplay":"Endocrine Disruptors","SubstanceName":"ETHYLENE GLYCOL MONOMETHYL ETHER","CasNumber":"109-86-4","Concentration":0.1,"UnitOfMeasure":1,"UomDisplayValue":"%Wt","DeclareAnotherSubstance":null,"Id":"4b12709f-1142-4480-a345-2549270cf9a7","GroupQuestionIdentifier":"Q3001SubGrp19","ConcentrationOperator":0,"ConcentrationOperatorDisplayValue":" "}],"Total":7,"AggregateResults":null,"Errors":null}